Pharma’s emphasis on employing strict safety reporting guidelines from the design stage of a trial ensures the quality and efficiency of our services and the safety of patients who participate in our trials.

Our safety and pharmacovigilance experts ensure that a patient’s safety is paramount. Critical to the success of any clinical trial is the early identification and management of adverse events.

Pharsh Pharma has a dedicated safety group employed at all stages of a trial to identify and coordinate the management of adverse events.

Our experienced safety and pharmacovigilance team provides:

• Full safety service requirements including safety database
• Tailored solutions for commercial and academic research across all phases
• A thorough understanding of safety reporting requirements across trial countries